{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:15:38Z","timestamp":1776903338559,"version":"3.51.2"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bpg.2024.101893","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T13:30:42Z","timestamp":1708090242000},"page":"101893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma"],"prefix":"10.1016","volume":"68","author":[{"given":"Zaheer","family":"Nabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"\u017borniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Nageshwar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2024.101893_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1477-3163.151940","article-title":"Cancer review: cholangiocarcinoma","volume":"14","author":"Ghouri","year":"2015","journal-title":"J Carcinog"},{"key":"10.1016\/j.bpg.2024.101893_bib2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"Razumilava","year":"2014","journal-title":"Cholangiocarcinoma. Lancet."},{"key":"10.1016\/j.bpg.2024.101893_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102223","article-title":"New epidemiologic trends in cholangiocarcinoma","volume":"47","author":"Pascale","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/a-0659-9864","article-title":"Endoscopic biliary stenting: indications, choice of stents, and results: European society of gastrointestinal endoscopy (ESGE) clinical guideline - updated october 2017","volume":"50","author":"Dumonceau","year":"2018","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2024.101893_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41598-021-04297-2","article-title":"Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy","volume":"12","author":"Gonzalez-Carmona","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpg.2024.101893_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.gie.2017.10.029","article-title":"Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis","volume":"87","author":"Sofi","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1077794","article-title":"Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review","volume":"13","author":"Di Girolamo","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bpg.2024.101893_bib8","series-title":"Gastrointestinal and pancreatico-biliary diseases: advanced diagnostic and therapeutic endoscopy","article-title":"Intraductal ablation therapy in the biliary ductal system","author":"Nabi","year":"2022"},{"key":"10.1016\/j.bpg.2024.101893_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/den.12837","article-title":"Evaluation of the safety of endoscopic radiofrequency ablation for malignant biliary stricture using a digital peroral cholangioscope (with videos)","volume":"29","author":"Ogura","year":"2017","journal-title":"Dig Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gie.2010.09.031","article-title":"Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction","volume":"73","author":"Steel","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib11","first-page":"853","article-title":"Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction","volume":"33","author":"Cui","year":"2017","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.bpg.2024.101893_bib12","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s10620-014-3264-6","article-title":"Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?","volume":"59","author":"Sharaiha","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2024.101893_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50132-0","article-title":"Endoscopic radiofrequency ablation prolongs survival of patients with unresectable hilar cholangiocellular carcinoma - a case-control study","volume":"9","author":"Bokemeyer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpg.2024.101893_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gie.2020.12.016","article-title":"Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial","volume":"94","author":"Gao","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jhbp.1082","article-title":"Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: a pilot multicenter randomized comparative trial","volume":"29","author":"Kang","year":"2022","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.bpg.2024.101893_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4236\/jct.2015.611106","article-title":"Metal stenting with or without endobiliary radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma","volume":"6","author":"Liang","year":"2015","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.bpg.2024.101893_bib17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00464-013-3232-9","article-title":"Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications","volume":"28","author":"Dolak","year":"2014","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-0043-124870","article-title":"Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial","volume":"50","author":"Yang","year":"2018","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2024.101893_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MCG.0000000000001810","article-title":"Efficacy and safety of radiofrequency ablation plus stent versus stent-alone treatments for malignant biliary strictures: a systematic review and meta-analysis","volume":"57","author":"Khizar","year":"2023","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.gie.2022.09.025","article-title":"Endoscopic radiofrequency ablation for ingrowth occlusion after bilateral metal stent placement for malignant hilar biliary obstruction: a prospective pilot study","volume":"97","author":"Inoue","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib21","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/jgh.15967","article-title":"The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction","volume":"37","author":"Oh","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101893_bib22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.gie.2022.05.022","article-title":"Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial","volume":"96","author":"Albers","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2023-329700","article-title":"Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial","author":"Jarosova","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2024.101893_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9020019","article-title":"Oncologic photodynamic therapy: basic principles, current clinical status and future directions","volume":"9","author":"van Straten","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.bpg.2024.101893_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030585","article-title":"The current status of photodynamic therapy in cancer treatment","volume":"15","author":"Jiang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bpg.2024.101893_bib26","article-title":"PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer","volume":"3","author":"Pereira","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.bpg.2024.101893_bib27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.clinre.2014.10.015","article-title":"Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: a meta-analysis","volume":"39","author":"Lu","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3748\/wjg.v23.i7.1278","article-title":"Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: a systematic review and meta-analysis","volume":"23","author":"Moole","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2005-861294","article-title":"Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment","volume":"37","author":"Shim","year":"2005","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2024.101893_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5107(04)01288-X","article-title":"Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study","volume":"60","author":"Wiedmann","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib31","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1572-0241.2005.00318.x","article-title":"Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy","volume":"100","author":"Zoepf","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib32","doi-asserted-by":"crossref","first-page":"S494","DOI":"10.14309\/01.ajg.0000705924.89130.39","article-title":"S0969 photodynamic therapy for cholangiocarcinoma improves survival compared to standard of care chemotherapy - a ten-year single U.S. Center experience","volume":"115","author":"Hocker","year":"2020","journal-title":"Official journal of the American College of Gastroenterology | ACG"},{"key":"10.1016\/j.bpg.2024.101893_bib33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cgh.2007.12.004","article-title":"Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy","volume":"6","author":"Kahaleh","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101893_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.cgh.2007.02.021","article-title":"Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma","volume":"5","author":"Prasad","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101893_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1477-2574.2009.00102.x","article-title":"Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma","volume":"11","author":"Quyn","year":"2009","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bpg.2024.101893_bib36","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/hep.27905","article-title":"Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: a multicenter prospective phase II study","volume":"62","author":"Wagner","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2024.101893_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pdpdt.2016.10.001","article-title":"Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: a prospective study","volume":"16","author":"Yang","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.bpg.2024.101893_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.sla.0000217639.10331.47","article-title":"Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1\/r2 resection","volume":"244","author":"Witzigmann","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2024.101893_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1477-2574.2011.00424.x","article-title":"Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma","volume":"14","author":"Cheon","year":"2012","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bpg.2024.101893_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2050640616654037","article-title":"Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: a nationwide retrospective study of 150 consecutive applications","volume":"5","author":"Dolak","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.bpg.2024.101893_bib41","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.3748\/wjg.v18.i39.5589","article-title":"Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma","volume":"18","author":"Lee","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"Ortner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2024.101893_bib43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0016-5107(03)70021-2","article-title":"Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma","volume":"57","author":"Dumoulin","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/2050640615621235","article-title":"Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma","volume":"4","author":"Schmidt","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.bpg.2024.101893_bib45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.gie.2014.02.1030","article-title":"ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma","volume":"80","author":"Strand","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1227036","article-title":"Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy","volume":"13","author":"Mohring","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bpg.2024.101893_bib47","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/MCG.0000000000001524","article-title":"Photodynamic therapy (PDT), radiofrequency ablation (RFA) with biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"56","author":"Mohan","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib48","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/curroncol30020166","article-title":"Recent updates on local ablative therapy combined with chemotherapy for extrahepatic cholangiocarcinoma: photodynamic therapy and radiofrequency ablation","volume":"30","author":"Inoue","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.bpg.2024.101893_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tige.2022.01.008","article-title":"Intraductal therapies for cholangiocarcinoma","volume":"24","author":"Agnihotri","year":"2022","journal-title":"Techniques and Innovations in Gastrointestinal Endoscopy"},{"key":"10.1016\/j.bpg.2024.101893_bib50","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.brachy.2018.03.006","article-title":"Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter","volume":"17","author":"Deufel","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bpg.2024.101893_bib51","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1007\/s00464-023-10327-z","article-title":"Biliary self-expandable metallic stent combined with iodine-125 seeds in the treatment of malignant biliary obstruction (Bismuth type I or II)","volume":"37","author":"Chai","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib52","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1055\/s-0034-1392044","article-title":"Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma","volume":"47","author":"Mukewar","year":"2015","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2024.101893_bib53","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1572-0241.2006.00700.x","article-title":"A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma","volume":"101","author":"Simmons","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101893_bib54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00270-017-1827-6","article-title":"A systematic review and meta-analysis of intraluminal brachytherapy versus stent alone in the treatment of malignant obstructive jaundice","volume":"41","author":"Xu","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.bpg.2024.101893_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12885-023-10868-5","article-title":"Biliary drainage combined with simultaneous (125)I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpg.2024.101893_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2021.10.011","article-title":"A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma","volume":"165","author":"Taggar","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bpg.2024.101893_bib57","first-page":"254","article-title":"Radioactive stent insertion for inoperable hilar cholangiocarcinoma: a prospective randomized controlled trial","volume":"18","author":"Song","year":"2023","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"10.1016\/j.bpg.2024.101893_bib58","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2024.101893_bib59","article-title":"Combinatory local ablation and immunotherapies for hepatocellular carcinoma: rationale, efficacy, and perspective","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2024.101893_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/160250","article-title":"More than just tumor destruction: immunomodulation by thermal ablation of cancer","volume":"2011","author":"Haen","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.bpg.2024.101893_bib61","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3390\/curroncol29040182","article-title":"Endobiliary radiofrequency ablation combined with gemcitabine and cisplatin in patients with unresectable extrahepatic cholangiocarcinoma","volume":"29","author":"Inoue","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.bpg.2024.101893_bib62","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.gie.2020.04.075","article-title":"Endoscopic radiofrequency ablation plus a novel oral 5-fluorouracil compound versus radiofrequency ablation alone for unresectable extrahepatic cholangiocarcinoma","volume":"92","author":"Yang","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2024.101893_bib63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/apt.15050","article-title":"Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma","volume":"49","author":"Gonzalez-Carmona","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2024.101893_bib64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5009\/gnl.2014.8.3.318","article-title":"Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma","volume":"8","author":"Hong","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.bpg.2024.101893_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/190708","article-title":"Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis","volume":"2012","author":"Knuppel","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.bpg.2024.101893_bib66","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ejca.2014.01.008","article-title":"Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma","volume":"50","author":"Park","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpg.2024.101893_bib67","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5009\/gnl15175","article-title":"Photodynamic therapy plus chemotherapy compared with photodynamic therapy alone in hilar nonresectable cholangiocarcinoma","volume":"10","author":"Wentrup","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.bpg.2024.101893_bib68","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.bpg.2024.101893_bib69","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S2468-1253(22)00043-7","article-title":"Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study","volume":"7","author":"Oh","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101893_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6912","article-title":"Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma","author":"Monge","year":"2024","journal-title":"Cancer Med"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169182400012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169182400012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T04:54:27Z","timestamp":1711774467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169182400012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":70,"alternative-id":["S152169182400012X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2024.101893","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2024.101893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101893"}}